— Know what they know.
Not Investment Advice
Also trades as: RVX.TO (TSX) · $vol 0M

RVXCF OTC

Resverlogix Corp.
1W: -10.3% 1M: -11.2% 3M: -7.2% YTD: -9.5% 1Y: -11.2% 3Y: -19.8% 5Y: -88.5%
$0.06
-0.00 (-0.08%)
 
Weekly Expected Move ±13.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $19.7M mcap · 231M float · 0.0095% daily turnover · Short 55% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$331K +0.0% ▲
Operating Income
-$5M +0.0% ▲
Net Income
-$8M +0.0% ▲
EPS (Diluted)
$-0.03 +0.0% ▲
EBITDA
-$4M +0.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2021FY2022FY2024
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$331K
Gross Profit$0$0$0$0-$331K
Gross Margin—————
R&D Expenses$32M$16M$5M$6M$3M
SG&A Expenses$7M$6M$11M$7M$2M
Operating Expenses$39M$23M$16M$13M$4M
Operating Income$86M-$23M-$16M-$13M-$5M
Operating Margin—————
Interest Expense$6M$3M$727K$2M$3M
Income Before Tax-$163M$118M-$25M-$4M-$8M
Tax Expense$29K$27K$12K$18K$14K
Net Income-$163M$118M-$25M-$4M-$8M
Net Margin—————
EPS (Diluted)$-0.87$0.54$-0.10$-0.01$-0.03
EBITDA$86M-$22M-$15M-$12M-$4M
Shares Outstanding188M221M240M254M277M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms